MENU

Robert Uzzo Receives SUO Medal for Contributions to Urologic Oncology

May 16, 2018

Robert G. Uzzo, MD, FACS, professor and chair of the Department of Surgical Oncology at Fox Chase Cancer Center, received the 2018 Society of Urologic Oncology (SUO) Medal, presented to one member of SUO annually.Robert G. Uzzo, MD, FACS, professor and chair of the Department of Surgical Oncology at Fox Chase Cancer Center, received the 2018 Society of Urologic Oncology (SUO) Medal, presented to one member of SUO annually.

PHILADELPHIA (May 16, 2018) – Robert G. Uzzo, MD, FACS, professor and chair of the Department of Surgical Oncology at Fox Chase Cancer Center, received the 2018 SUO Medal from the Society of Urologic Oncology (SUO) for his significant contributions to the field of urologic oncology. This prestigious award is presented to one member of SUO annually, and is among the organization’s highest honors.

As both a surgeon and researcher, Uzzo is an internationally renowned leader in the field of urologic oncology. His interests include organ preserving surgeries, robotic and minimally invasive surgeries, complex urological reconstructions, adjuvant therapies for his risk urologic tumors and, non-surgical management of low risk tumors. He is a national principal investigator on multiple adjuvant kidney cancer clinical trials evaluating both targeted anti-angiogenic and immunotherapies. He is currently the president of the SUO Clinical Trials Consortium and the author of more than 400 chapters, articles, books, and abstracts on urologic tumors, and has presented hundreds of regional, national, and international lectures. 

A fellow of the American College of Surgeons and the prestigious American Association of Genitourinary Surgeons, Uzzo has consistently ranked among Castle Connolly’s and Philadelphia magazine's "Top Docs" in urology. He joined Fox Chase in 2000.

Since 1984, the SUO has been dedicated to research and education in urologic oncology, with the aim of caring for patients with malignant genitourinary diseases.

Uzzo will accept the SUO Medal at the upcoming combined spring meeting of the SUO and the American Urology Association. Among many honors, he is the recipient of the 2017 SUO President’s Distinguished Service Award and the 2014 AUA Residents Committee Teaching Award.

       

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. 
For more information, call 1-888-FOX CHASE or (1-888-369-2427).

Connect with Fox Chase